Developer of an AI-driven precision medicine platform designed for canine cancer treatment. The company leverages next-generation sequencing and clinical data to analyze naturally occurring canine cancers, maintaining a proprietary database for cancer analysis and provides genomic sequencing services and targeted therapy recommendations for dogs with cancer to deliver precision medicine solutions that improve treatment outcomes, enabling veterinarians to deliver personalized treatment plans that address the unique characteristics of each dog's cancer.